Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Adenovirus vector-based multi-epitope vaccine provides partial protection against H5, H7, and H9 avian influenza viruses

12 Oct 2017

Abstract excerpt

The emergence of H5, H7, and H9 avian influenza virus subtypes in humans reveals their pandemic potential. Although human-to-human transmission has been limited, the genetic reassortment of the avian and human/porcine influenza viruses or mutations in some of the genes resulting in virus replication in the upper respiratory tract of humans could generate novel pandemic influenza viruses. Current vaccines do not...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Influenza Virus Research Studies
Share to Respiratory viral infections research
Share to Viral gastroenteritis research and epidemiology

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29023601
DOI: 10.1371/journal.pone.0186244

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Adenovirus vector-based multi-epitope vaccine provides partial protection against H5, H7, and H9 avian influenza virusesPMID 29023601Read ↗

Production of adenovirus vectors and their use as a delivery system for influenza vaccinesSemantic proximity Read ↗

A Broadly Protective Vaccine against Globally Dispersed Clade 1 and Clade 2 H5N1 Influenza VirusesSemantic proximity Read ↗

Next-Generation Adenoviral Vector-Based Vaccines for Severe Acute Respiratory Syndrome Coronavirus-2Semantic proximity Read ↗

A VSV-vector vaccine simultaneously targeting H5N1 hemagglutinin (HA) and matrix protein 2 (M2) induces robust neutralizing and ADCC antibody responses and provides full protection against lethal H5N1 infection in a mouse modelSemantic proximity Read ↗

A Model H5N2 Vaccine Strain for Dual Protection Against H5N1 and H9N2 Avian Influenza VirusesSemantic proximity Read ↗

A 10-valent composite mRNA vaccine against both influenza and COVID-19Semantic proximity Read ↗

Recombinant Influenza VaccinesSemantic proximity Read ↗

Avian Influenza Clade 2.3.4.4b: Global Impact and Summary Analysis of Vaccine TrialsSemantic proximity Read ↗

Adenovirus vector-based vaccine for infectious diseasesSemantic proximity Read ↗

Intranasal HD-Ad Vaccine Protects the Upper and Lower Respiratory Tracts of hACE2 Mice against SARS-CoV-2Semantic proximity Read ↗

Both haemagglutinin-specific antibody and T cell responses induced by a chimpanzee adenoviral vaccine confer protection against influenza H7N9 viral challengeSemantic proximity Read ↗

A Bovine Adenoviral Vector-Based H5N1 Influenza -Vaccine Provides Enhanced Immunogenicity and Protection at a Significantly Low DoseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.